๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
SHR4640 tablets is a highly selective and potent URAT1 inhibitors,study num...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-15
Trial ID
NCT05513976
Treatments Being Tested
The goal of this clinical trial is to compare the changes in serum urate le...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-09-10
Trial ID
NCT06622603
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of HR09150...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04-30
Trial ID
NCT05347498
The aim of this study is to evaluate the efficacy and safety of simiaowan i...
Status
Unknown
Location
Guang'anmen Hospital
Start Date
2019-09-01
Trial ID
NCT04069325
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of HR0915...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT06414837
This study was designed to evalute the efficacy and safety of Febuxostat af...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00821392
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of A...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Science
Start Date
2024-04-22
Trial ID
NCT06603142
The Purpose of this study is to determine if the Febuxostat has an effect o...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02866214
Treatments Being Tested
A total of 120 obese gout patients were included in a 24-week double-blind ...
Status
Not Yet Recruiting
Location
General Hospital of Northern Theater Command, PLA
Start Date
2025-12-10
Trial ID
NCT07326839
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of HR0915...
Status
Completed
Location
Peking University First Hospital
Start Date
2023-12-14
Trial ID
NCT06139393